Clinical Trial Update: Mesenchymal Stem Cells in Critical Limb Ischemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating mesenchymal stem cells for critical limb ischemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Stempeutics Research Pvt Ltd | Conditions: Critical Limb Ischemia | Phase 1, Phase 2 | Status: COMPLETED